Table 4 Antibiotics prescribed to patients during ICU stay
From: Pattern of antibiotic use and bacterial co-infection in hospitalized Covid-19 patients
Antibiotics | Responses | Cumulative percentage of Cases | |
|---|---|---|---|
N | Percent | ||
Levofloxacin | 70 | 21.10% | 59.30% |
Meropenem | 59 | 17.80% | 50.00% |
Linezolid | 55 | 16.60% | 46.60% |
Cefepime | 42 | 12.70% | 35.60% |
Clarithromycin | 23 | 6.90% | 19.50% |
Ceftazidime | 16 | 4.80% | 13.60% |
Piperacillin/Tazobactam | 14 | 4.20% | 11.90% |
Ceftriaxone | 14 | 4.20% | 11.90% |
Amikacin | 6 | 1.80% | 5.10% |
Tigecycline | 5 | 1.50% | 4.20% |
Moxifloxacin | 5 | 1.50% | 4.20% |
Imipenem/Cilastatin | 4 | 1.20% | 3.40% |
Teicoplanin | 4 | 1.20% | 3.40% |
Ciprofloxacin | 3 | 0.90% | 2.50% |
Colistin | 3 | 0.90% | 2.50% |
Doxycycline | 3 | 0.90% | 2.50% |
Azithromycin | 3 | 0.90% | 2.50% |
Clindamycin | 2 | 0.60% | 1.70% |
Vancomycin | 1 | 0.30% | 0.80% |
Total | 332 | 100.0% | 281.4% |